Clinical Trials Browser

Phase 2 × Tetanus Toxoid × Plasma cell × Clear all

NCT02700841 2024-03-12

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

Phase 2 Terminated

8 enrolled 8 charts

Multiple Myeloma